{"filings":[{"id":2631756,"accession_number":"0001193125-26-380215","cik":2058707,"company_name":"Attovia Therapeutics, Inc.","ticker":"ATTO","form_type":"8-K","filed_at":"2026-09-02T20:17:18+00:00","items":["2.02","9.01"],"status":"ready","headline":"Attovia Q2 2026 net loss $20.7M; ATTO-1310 proof-of-concept; IPO funds runway to 2030","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2026 net loss $20.7M vs $14.4M year ago; R&D $18.9M vs $13.6M; collaboration revenue $0.5M.","Cash $115.1M at 6/30/26; plus $305.4M net IPO proceeds (Aug '26) extends runway into 2030.","ATTO-1310 Phase 1b shows rapid itch relief in chronic pruritus and high-itch AD; full data Q4 2026.","Phase 2 studies in CPUO and high-itch AD planned 1H 2027; Phase 1 for ATTO-2306/1091 also 1H 2027.","IPO gross proceeds $332.4M; board strengthened with John W. Smither appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2106083,"accession_number":"0001193125-26-338037","cik":2058707,"company_name":"Attovia Therapeutics, Inc.","ticker":"ATTO","form_type":"8-K","filed_at":"2026-08-06T20:12:58+00:00","items":["5.03","9.01"],"status":"ready","headline":"Attovia Therapeutics closes IPO, adopts amended charter and bylaws","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["IPO closed on August 6, 2026; amended charter and bylaws became effective.","Common stock trades on Nasdaq under ticker ATTO.","Prospectus dated August 4, 2026 describes capital stock provisions.","Company qualifies as an emerging growth company under SEC rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":null,"market_cap_as_of_date":null,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}